P2RY12 and atrial fibrillation: In recent guidelines and expert consensus documents of antithrombotic therapy for patients with ischemic heart disease, dual antithrombotic therapy with a P2Y12 inhibitor plus OAC is commonly recommended in atrial fibrillation (AF) patients after PCI [2–7].